Lithium and antidepressants: Stimulating immune function and preventing and reversing infection

Medical Hypotheses

Volumn 69, Issue 1, 2007, Pages 8-11

  Lieb, Julian ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; FLUOXETINE; IPRONIAZID; ISONIAZID; LITHIUM; LITHIUM CARBONATE; LITHIUM CHLORIDE; MONOAMINE OXIDASE INHIBITOR; PROSTAGLANDIN E2; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOLOGICAL WARFARE; CELLULAR IMMUNITY; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; DRUG MECHANISM; DRUG WITHDRAWAL; EPIDEMIC; EVIDENCE BASED MEDICINE; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION; INFECTION PREVENTION; MICROORGANISM; PANDEMIC; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REMISSION; SURGICAL INFECTION; TREATMENT RESPONSE; TUBERCULOSIS;

ANTI-INFECTIVE AGENTS; ANTIDEPRESSIVE AGENTS; HUMANS; IMMUNITY, NATURAL; INFECTION; INFECTION CONTROL; LITHIUM COMPOUNDS; MODELS, IMMUNOLOGICAL;

EID: 34247587115     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.12.005     Document Type: Article

References (64)

1. Bankhurst A. The modulation of human natural killer cell activity by prostaglandins. J Clin Lab Immunol 7 (1982) 8591
2. Cattan N., Mary D., Peleraux A., et al. Prostaglandin E2 delivers a co-stimulatory signal leading to T cell activation. Eur Cytokine Netw 11 2 (2000) 293-299
3. Steinbrink K., Paragnik L., Jonuleit H., et al. Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins. Arch Dermatol Res 292 9 (2000) 437-445
4. Goldyne M.E., and Stobo J.D. Prostaglandin E2 as a modulator of macrophage-T lymphocyte interactions. J Invest Dermatol 74 (1980) 297-300
5. Moriuchi M., Inoue H., and Moriuchi H. Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission. J Virol 75 1 (2001) 192-198
6. Fernandez-Cruz E., Gelpi E., Longo N., et al. Increased synthesis and production of prostaglandin E2 by monocytes from drug addicts with AIDS. Aids 3 (1989) 93-96
7. Tarter T., Cunningham-Rundles S., Laurence J., et al. Soluble factor of transformed B-lymphocytes in patients with HIV infection stimulates monocytes to produce prostaglandin E2. Clin Immunol Immunopathol 82 3 (1997) 303-305
8. Wahl L., Corcoran M., Pyle S., et al. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci USA 86 (1989) 621-625
9. Maccarrone M., Bari M., Corasaniti M.T., Nistico R., Bagetta G., and Finazzi-Agro A. HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids. J Neurochem 75 1 (2000) 196-203
10. Griffin D., Wesselingh S., and McArthur J. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 35 5 (1994) 592-597
11. Dumais N., Barbeau B., Olivier M., and Tremblay M.J. Prostaglandin E2 up-regulates HIV-1 long terminal repeat-driven gene activity in T cells via NF-kappa B-dependent and -independent signaling pathways. J Biol Chem 273 42 (1998) 27306-27314
12. Daugschies A., and Joachim A. Eicosanoids in parasitic infections. Adv Parasitol 461 (2000) 181-240
13. Angeli V, Faveeuw C, Roye O et al., Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection.
14. Milano S., Arcoleo F., Dieli M., et al. Ex vivo evidence for prostaglandin E2 and leukotriene B4 involvement in cutaneous leishmaniasis: relations with infection status and cytokine production. Parasitology 112 Pt1 (1996) 13-19
15. Stenson W.F., Zhang Z., Riehl T., and Stanley Jr. S.L. Amebic infection in the human colon induces cyclooxygenase-2. Infect Immunol 69 5 (2001) 3382-3388
16. Ali S., Joachim A., Daugschies A., et al. Eicosanoid production by adult Fasciola hepatica and plasma eicosanoid patterns during fasciolosis in sheep. Int J Parasitol 29 5 (1999) 743-748
17. Pinge-Filho P., Tadokoro C.E., and Abrahamsohn I.A. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanasoma cruzi infection. Cell Immunol 193 1 (1999) 90-98 10
18. Alcantara C., Stenson W.F., Steiner T.S., and Guerrant R.L. Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A-induced secretion and inflammation in an animal model. J Infect Dis 184 5 (2001) 648-652
19. Hahn E.L., Tai H.H., He L.K., and Gamelli R.L. Burn injury with infection alters prostaglandin E2 synthesis and metabolism. J Trauma 47 6 (1999) 1052-1057
20. Gamelli R.L., He L.K., and Liu L.H. Macrophage mediated suppression of granulocyte and macrophage growth after burn wound infection reversal by means of anti-prostaglandin E2. J Burn Care Rehabil 21 1 Pt 1 (2000) 64-69
21. Yoshikai Y. Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection. Curr Opin Infect Dis 14 3 (2001) 257-263
22. Mikamo H., Kawazoe K., Sato Y., Imai A., and Tamaya T. Preterm labor and bacterial intra-amniotic infection: arachidonic acid liberation by phospholipase A2 of Fusobacterium nucleatum. Am J Obstet Gynecol 179 6Pt 1 (1998) 1579-1582
23. Qadri F., Raqib R., Ahmed F., et al. Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin Diagn Lab Immunol 9 2 (2002) 221-229
24. Rangel M., Estrada G., De La Luz G., et al. The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106 2 (2002) 257-266
25. Noverr M.C., Phare S.M., Toews G.B., Coffey M.J., and Hufnagle G.B. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun 69 5 (2001) 2957-2963
26. Deva R., Ciccoli R., Schewe T., Kock J.L., and Nigam S. Arachidonic acid stimulates cell growth and forms a novel oxygenated metabolite in Candida albicans. Biochim Biophys Acta 1486 2-3 (2000) 299-311
27. Yirmiya R., Barak O., Avitsur R., Gallily R., and Weidenfeld J. Intracerebral administration of Mycoplasma fermentans produces sickness behavior: role of prostaglandins. Brain Res 749 1 (1977) 71-81
28. Kock J.L., Venter P., Botha A., Coetzee D.J., Botes P.J., and Nigam S. The production of biologically active eicosanoids by yeasts. Adv Exp Med Biol 433 (1997) 217-219
29. Horrobin D., Mtabaji J., Manku M., et al. Lithium as a regulator of hormone-stimulated prostaglandin synthesis. Lithium in medical practice (1978), University Park Press, Baltimore pp 243-263
30. Murphy D., Donnelly C., and Moskowitz J. Inhibition by lithium of prostaglandin E1 and norepinephrine effects on cyclic adenosine monophosphate production in human platelets. Clin Pharmacol Ther 14 5 (1973) 810-814
31. Chang M., Grange E., Rabin O., et al. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci Lett 220 (1996) 171-174
32. Lee R. The influence of psychotropic drugs on prostaglandin biosynthesis. Prostaglandins 5 1 (1974) 63-68
33. Hong S., Carty T., and Deykin D. Tranylcypromine and 15-hydroperoxyarachidonate affect arachidonic acid release in addition to inhibition of prostacyclin synthesis in calf aortic endothelial cells. J Biol Chem 225 20 (1983) 9538-9540
34. Janicke U., and Forster W. Effects of imipramine, chlorpromazine and promazine pretreatment on the in vitro prostaglandin biosynthesis of rabbit brain and renal medulla. Pharmacol Res Comm 9 5 (1977) 501-507
35. Manku M.S., and Horrobin D.F. Chloroquine, quinine, procaine, quinidine and clomipramine are prostaglandin agonists and antagonists. Prostaglandins 12 (1976) 789-801
36. Yaron I., Shirazi I., Judovich R., Levartovsky D., Caspi D., and Yaron M. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum 42 12 (1999) 2561-2568
37. Ellis E., Rosenblum W., Birkle D., Traweek D.L., and Cockrell C.S. Lowering the brain levels of the depressant prostaglandin D2 by the antidepressant tranylcypromine. Biochem Pharmacol 31 9 (1982) 1783-1784
38. Lieb J. Remission of herpes virus infection and immunopotentiation with lithium carbonate: inhibition of prostaglandin E1 synthesis by lithium may explain its antiviral, immunopotentiating, and antimanic properties. Biol Psychiat (1981) 695-698
39. Hansell N. Manic illness presenting with physical symptoms. Am J Psychiatry 147 11 (1990) 1575
40. Amsterdam J., Maislin G., and Rybakowski J. A possible antiviral action of lithium carbonate in herpes simplex virus infections. Biol Psychiat 27 (1990) 447-453
41. Shenkman L., Borkowsky W., and Shopsin B. Lithium as an immunologic adjuvant. Med Hypothesis 6 (1980) 1-6
42. Skinner G., Hartley C., Buchan A., Harper L., and Gallimore P. The effect of lithium chloride on the replication of herpes simplex virus. Med Microbiol Immunol 168 (1980) 139-148
43. Weetman A., McGregor A., Lazarua J., Smith B.R., and Hall R. The enhancement of immunoglobulin synthesis by human lymphocytes with lithium. Clin Immunol 22 (1982) 400-407
44. Lieb J. Remission of rheumatoid arthritis and other disorders of immunity in patients taking monoamine oxidase inhibitors. Int J Immunopharmacol 5 4 (1983) 353-357
45. Rosenthal S., and Fitch W. The antiherpetic effects of phenelzine. J Clin Psychopharmacol 7 2 (1987) 119
46. Lofft J. MAO inhibitors. Psychiat Times Nov, 1985.
47. Graff-Radford S.B., Shaw L.R., and Naliboff B.N. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 16 3 (2000) 188-192
48. Zilberstein D., and Dwyer D. Antidepressants cause lethal disruption of membrane function in the human protozoan parasite leishmania. Science 226 (1984) 977
49. Weinbach E., Costa J., and Wieder S. Antidepressant drugs suppress growth of the human pathogenic protozoan giardia lamblia. Res Commun Chem Pathol Pharm 47 1 (1985) 145-148
50. Weinbach E., Levenbook L., and Alling D. Binding of tricyclic antidepressant drugs to trophozoites of Giardia lamblia. Comp Biochem Physiol C. 102 3 (1992) 391-396
51. Bitionti A., Sjoerdsma A., McCann P., et al. Reversal of chloroquine resistance in malaria parasite plasmodium falciparum by desipramine. Science 242 48883 (1988) 1301-1303
52. Salama A., and Facer C. Desipramine reversal of chloroquine resistance in wild isolates of plasmodium falciparum. Lancet 335 (1990) 164-165
53. Dutta P., Pinto J., and Rivlin R. Antimalarial properties of imipramine and amitriptyline. J Protozool 37 1 (1990) 54-58
54. Coutaux A., Mooney J., and Wirth D. Neuronal monoamine reuptake inhibitors enhance in vitro susceptibility to chloroquine in resistant Plasmodium falciparum. Antimicrob Agents Chemother 38 6 (1994) 1419-1421
55. Doyle P., and Weinbach E. The activity of tricyclic antidepressant drugs against Trypanosoma cruzi. Exp Parasitol. 68 2 (1989) 230-234
56. Lass-Florl C., Dierich M.P., Fuchs D., Semenitz E., and Ledechowski M. Antifungal activity against Candida species of the selective serotonin reuptake inhibitor sertraline. Clin Infect Dis 33 12 (2001) E135-E136 Epub 2001 Nov7
57. Lass-Florl C., Dierich M., Fuchs D., Semenitz E., Jenewein I., and Ledechowski M. Antifungal properties of selective serotonin reuptake inhibitors against aspergillus species in vitro. J Antimicrob Chemother 48 (2001) 775-779
58. Munoz-Bellido J., Munoz-Criado S., and Garcia-Rodriguez J. Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors. Int J Antimicrob Agents 14 3 (2000) 177-180
59. Munoz-Bellido J., Munoz-Criado S., and Garcia-Rodriguez J. In-vitro activity of psychiatric drugs against Corynebacterium unrealyticum (Corynebacterium group D2). J Antimicrob Chemother 37 5 (1996) 1005-1009
60. Calabrese J., Skwerer R., Barna B., et al. Depression, immunocompetence, and prostaglandins of the E series. Psychiat Res 17 (1984) 41-47
61. Evans D.L., Pedersen C.A., and Folds J.D. Major depression and immunity: Preliminary evidence of decreased natural killer cell populations. Prog Neurol-Psychopharmacol Biol Psychiat 12 (1988) 739-774
62. Frank M., Hendricks S., Johnson D., Wieselewr J.L., and Burke W.J. Antidepressants augment natural killer cell activity: in vivo and in vitro. Neuropsychobiology 39 1 (1999) 18-24
63. Leung K., and Mihich E. Prostaglandin modulation of development of cell-mediated immunity in culture. Nature 288 (1980) 597-600
64. Abouesh A., Stone C., and Hobbs W. Antimicrobial-induced mania (antibiomania): a review of spontaneous reports. J Clin Psychopharmacol 22 1 (2002) 71-81